Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three months prospective study

Misbah Noshela Ghazanfar; Ewa Anna Bartko; Nicolai Skovbjerg Arildsen; Lars K Poulsen; Bettina Margrethe Jensen; Christian Enevold; Jesper Grønlund Holm; Anders Woetmann; Niels Ødum; Simon Francis Thomsen

doi:10.1111/cea.14121

Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three months prospective study

Misbah Noshela Ghazanfar, Ewa Anna Bartko, Nicolai Skovbjerg Arildsen, Lars K Poulsen, Bettina Margrethe Jensen, Christian Enevold, Jesper Grønlund Holm, Anders Woetmann, Niels Ødum, Simon Francis Thomsen

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning

4 Citationer (Scopus)

35 Downloads (Pure)

Originalsprog	Engelsk
Tidsskrift	Clinical and Experimental Allergy
Vol/bind	52
Antal sider	4
ISSN	0954-7894
DOI	https://doi.org/10.1111/cea.14121
Status	Udgivet - 2022

Adgang til dokumentet

10.1111/cea.14121Licens: CC BY-NC-ND

FulltextForlagets udgivne version, 604 KBLicens: CC BY-NC-ND

Citationsformater

Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria : A three months prospective study. / Noshela Ghazanfar, Misbah; Bartko, Ewa Anna; Arildsen, Nicolai Skovbjerg ; Poulsen, Lars K; Jensen, Bettina Margrethe; Enevold, Christian; Holm, Jesper Grønlund; Woetmann, Anders ; Ødum, Niels ; Thomsen, Simon Francis.

I: Clinical and Experimental Allergy, Bind 52, 2022.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning

Noshela Ghazanfar, Misbah ; Bartko, Ewa Anna ; Arildsen, Nicolai Skovbjerg ; Poulsen, Lars K ; Jensen, Bettina Margrethe ; Enevold, Christian ; Holm, Jesper Grønlund ; Woetmann, Anders ; Ødum, Niels ; Thomsen, Simon Francis. / Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria : A three months prospective study. I: Clinical and Experimental Allergy. 2022 ; Bind 52.

@article{29cf65aeac8c4242a9e17045e706ceb0,

title = "Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three months prospective study",

author = "{Noshela Ghazanfar}, Misbah and Bartko, {Ewa Anna} and Arildsen, {Nicolai Skovbjerg} and Poulsen, {Lars K} and Jensen, {Bettina Margrethe} and Christian Enevold and Holm, {Jesper Gr{\o}nlund} and Anders Woetmann and Niels {\O}dum and Thomsen, {Simon Francis}",

year = "2022",

doi = "10.1111/cea.14121",

language = "English",

volume = "52",

journal = "Clinical Allergy",

issn = "0954-7894",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria

T2 - A three months prospective study

AU - Noshela Ghazanfar, Misbah

AU - Bartko, Ewa Anna

AU - Arildsen, Nicolai Skovbjerg

AU - Poulsen, Lars K

AU - Jensen, Bettina Margrethe

AU - Enevold, Christian

AU - Holm, Jesper Grønlund

AU - Woetmann, Anders

AU - Ødum, Niels

AU - Thomsen, Simon Francis

PY - 2022

Y1 - 2022

U2 - 10.1111/cea.14121

DO - 10.1111/cea.14121

M3 - Comment/debate

C2 - 35278253

VL - 52

JO - Clinical Allergy

JF - Clinical Allergy

SN - 0954-7894

ER -